ROIV

38.6000.92%
RP

Richard Pulik

Chief Financial Officer

Mr. Richard Pulik serves as Principal Financial Officer at Roivant Sciences Ltd. since September 28, 2021. He serves as Chief Financial Officer at Roivant Sciences, Inc. since September 28, 2021. He brings experience in the biopharmaceutical industry and finance. He was Global Head of Business Development & Licensing & Portfolio Management - Oncology at Novartis AG. Mr. Pulik was a member of Novartis’s Innovation Management Board and the Novartis Oncology Leadership Team, from August 2019 to September 2021. Mr. Pulik joined Novartis in 2012 as a Senior Director, Mergers & Acquisitions based in Basel, Switzerland working on the strategy and execution of the deals that shaped Novartis. In 2015, Mr. Pulik was appointed as Vice President, Head of North America Investor Relations for Novartis. Prior to these roles at Novartis, Mr. Pulik worked at Bank of America Merrill Lynch, Monitor Group and UBS Investment Bank, focusing on mergers and acquisitions and strategy in the healthcare sector. Mr. Pulik received a B.S. in Finance from The Wharton School and a B.A. in Economics and International Relations at the University of Pennsylvania in 2001.

Positions